Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -38.9% | -5.2% | 2 / 3 | +14.7% | +1.30 pp | -3.51 pp | +9.4% | 0.73 | 18.01 | 2.683 | +14,7% | 191 | −23,2% | 18.01 | 8.57 | +110,2% |
| Pts | 0 | 0 | 8 | 4 | 8 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 25.300 (close price on 2026-10-19)EPS (TTM): 1.405
Financial charts
1.Revenue & growth
VND bn2.683Q2/26
1.Revenue & growth
VND bn2.683Q2/26
2.Profit & growth
VND bn156Q2/26
3.Profit mix (Penman)
VND bn624Q2/26
4.Margins & cost structure
%28.7%Q2/26
5.Returns & cash cycle
% · days8.1%Q2/26
6.Earnings quality & cash
VND bn225Q2/26
7.Asset structure
VND bn11.776Q2/26
8.Funding & debt health
VND bn · times11.776Q2/26
9.Revenue backlog
VND bn5,65Q2/26
10.Valuation
times · %18,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %458Q2/26
Adjusted EPS growth, latest quarter
-38.1%
Average adjusted EPS growth, 3 quarters
-5.0%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
3.4%
Source: vnstockData through Q2/26